Oncologic immunomodulatory agents in patients with cancer and COVID-19
Abstract Corticosteroids, anti-CD20 agents, immunotherapies, and cytotoxic chemotherapy are commonly used in the treatment of patients with cancer. It is unclear how these agents affect patients with cancer who are infected with SARS-CoV-2. We retrospectively investigated associations between SARS-C...
Guardado en:
Autores principales: | Justin Jee, Aaron J. Stonestrom, Sean Devlin, Teresa Nguyentran, Beatriz Wills, Varun Narendra, Michael B. Foote, Melissa Lumish, Santosha A. Vardhana, Stephen M. Pastores, Neha Korde, Dhwani Patel, Steven Horwitz, Michael Scordo, Anthony F. Daniyan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac5a7ce592fd4888901daa72413e1e59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Immunomodulatory Functions of Butyrate
por: Siddiqui MT, et al.
Publicado: (2021) - Oncology
-
Immunomodulatory Effects of Nanoparticles on Skin Allergy
por: Samreen Jatana, et al.
Publicado: (2017) -
IMMUNOMODULATORY EFFECTS OF XIMEDONUM IN PATIENTS WITH TOXICODERMIA
por: L. U. Yusupova, et al.
Publicado: (2014) - Oncology letters